Abpro Holdings, Inc. Warrant (ABPWW)

• 1 day: -11.03%
• 5 days: -37.95%
• 1 month: -40.10%
• 3 months: -70.56%
• 6 months: -79.83%
• Year to date: -85.42%
• 1 year: -75.80%
• 5 years: -93.95%
• 10 years: -93.95%
• Sector: Healthcare
• Industry: Biotechnology

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Employees: 6

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

7% less funds holding

Funds holding: 27 [Q4 2024] → 25 (-2) [Q1 2025]

60% less capital invested

Capital invested by funds: $604K [Q4 2024] → $243K (-$361K) [Q1 2025]

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2